Sleep breathing disorders in heart failure

AC Coniglio, RJ Mentz - Cardiology Clinics, 2022 - cardiology.theclinics.com
Sleep-disordered breathing (SDB) has become an increasingly recognized cause of
morbidity and mortality in adults, and is largely underdiagnosed and undertreated. SDB is …

[HTML][HTML] Sleep apnea and sudden death in the non-cardiac population: A systematic review

ABR Martinez, GR Barbosa, MR Lopes… - Revista Portuguesa de …, 2024 - Elsevier
Introduction Obstructive sleep apnea (OSA) is one of the main risk factors for cardiovascular
diseases and is associated with both morbidity and mortality. OSA has also been linked to …

[HTML][HTML] Validation Against Polysomnography of a Transthoracic Impedance Sensor for Screening of Sleep Apnea in Heart Failure Patients: A Pooled Analysis of …

F Barbieri, A Adukauskaite, P Spitaler… - Journal of Clinical …, 2024 - mdpi.com
Background/Introduction: Cardiac implantable electronic devices and their integrated
thoracic impedance sensors have been used to detect sleep apnea for over a decade now …

Sleep quality and its underrated role: Associations between sleep-related symptoms and cardiovascular biomarkers

JA Laukkanen, SK Kunutsor - International …, 2024 - internationaljournalofcardiology.com
Journal Pre-proof factors such as physical inactivity, tobacco use, sleep quality, and duration
are closely associated with CVDs. Prior studies, including ours, have highlighted the …

Changes in cardiac conduction time following cardiac resynchronization therapy: rationale and design of the RECOVER study

HB Gwag, JS Kim, KM Park, YK On, SJ Park - Journal of Interventional …, 2022 - Springer
Background It has been known that ventricular conduction delays play a key role in the
cardiac resynchronization therapy (CRT) response of patients with advanced heart failure …

Central sleep apnea in patients with heart failure: whom to screen and how to treat?–A brief review

CI Borcea, FD Mihălțan, OC Deleanu - Pneumologia - sciendo.com
Heart failure (HF) remains a significant public health problem despite the advances in
therapies and prevention (1). Up to 80% of the patients with chronic HF are associated with …